Eli Lilly to Acquire Gene-Editing Therapy Developer Verve Therapeutics for up to $1.3 Billion, Companies Say (Reuters) -Eli Lilly will acquire Verve Therapeutics for up to $1.3 billion, the ...

Telehealth partners for Eli Lilly (LLY) continue to sell compounded GLP-1 weight-loss drugs despite an agreement with the pharma giant to end copycat sales after the FDA ended a years-long ...

Eli Lilly's $1.3B offer for Verve Therapeutics is a lifeline, providing a 70%+ premium and a solid exit for Verve investors. VERV struggled as a standalone due to tough gene therapy ...

Chugai Pharmaceutical Co. Ltd. (OTC:CHGCY) believes its anti-muscle-wasting drug could be used alongside Eli Lilly And Co.’s (NYSE:LLY) oral obesity pill, orforglipron. Roche Holdings AG (OTC ...

Today’s Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), The Home Depot, Inc. (HD), and SAP SE (SAP), as well as one micro-cap stock ...

One of the biggest healthcare companies in the world, Eli Lilly is known for its weight loss drugs. The company has a market cap of $729 billion and the stock is exchanging hands for $769.

Eli Lilly & Co. agreed to buy Verve Therapeutics Inc., a US biotech that’s seeking to use gene editing to prevent clogged arteries, for as much as $1.3 billion. Eli Lilly & Co. agreed to buy ...

Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug WEDNESDAY, June 18, 2025 (HealthDay News) — Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing ...

Arne Dedert / Picture Alliance / Getty Images Shares of Verve Therapeutics soared 75% Tuesday as Eli Lilly said it would acquire the gene-editing startup. The deal values Verve at about $1.3 ...

Eli Lilly offered a 115% premium for Verve, signaling a major vote of confidence in gene editing platforms. HC Wainwright and William Blair downgraded Verve after the deal. Last Chance: See the ...

Eli Manning has a connection to both as Arch's uncle and Dart as Ole Miss alums drafted by the New York Giants. Manning has plenty of experience to share with both young QBs, knowing exactly what ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Business Model Mastery’s Substack. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company (LLY ...